Kraus Sarah, Gioeli Daniel, Vomastek Tomas, Gordon Vicki, Weber Michael J
Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, Virginia, USA.
Cancer Res. 2006 Nov 15;66(22):11047-54. doi: 10.1158/0008-5472.CAN-06-0596.
The androgen receptor (AR) remains functionally important in the development and progression of prostate cancer even when the disease seems androgen "independent." Because signal transduction by growth factor receptors increases in advanced prostate cancer and is capable of sensitizing the AR to androgen, there is considerable interest in determining the mechanisms by which signaling systems can modulate AR function. We show herein that the adaptor/scaffolding protein receptor for activated C kinase 1 (RACK1), which was previously reported to interact with the AR, modulates the tyrosine phosphorylation of AR and its interaction with the Src tyrosine kinase. We also show that down-regulation of RACK1 by short interfering RNA inhibits growth and stimulates prostate-specific antigen transcription in androgen-treated prostate cancer cells. Our results suggest that RACK1 mediates the cross-talk of AR with additional binding partners, such as Src, and facilitates the tyrosine phosphorylation and transcriptional activity of the AR.
雄激素受体(AR)在前列腺癌的发生和发展过程中仍具有重要的功能作用,即便在疾病看似处于雄激素“非依赖”状态时也是如此。由于晚期前列腺癌中生长因子受体的信号转导会增强,并且能够使AR对雄激素敏感,因此对于确定信号系统调节AR功能的机制存在相当大的兴趣。我们在此表明,之前报道可与AR相互作用的衔接/支架蛋白——活化C激酶1受体(RACK1),能够调节AR的酪氨酸磷酸化及其与Src酪氨酸激酶的相互作用。我们还表明,通过短发夹RNA下调RACK1可抑制雄激素处理的前列腺癌细胞的生长并刺激前列腺特异性抗原转录。我们的结果提示,RACK1介导AR与其他结合伴侣(如Src)之间的相互作用,并促进AR的酪氨酸磷酸化和转录活性。